Skip to content
Insider tapeLive · 5:42 PM ET
Watchlist

Andrew J Murphy

Co-Chief Scientific Officer at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.2M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 651,974 held (−0%) $753.76 $5K +6.8%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 3551,939 held (−0%) $755.91 $26K +6.5%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1651,923 held (−0%) $757.68 $12K +6.3%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2451,899 held (−0%) $758.16 $18K +6.2%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1451,885 held (−0%) $759.96 $11K +6.0%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 7451,811 held (−0%) $760.65 $56K +5.9%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2751,784 held (−0%) $761.36 $21K +5.8%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 5551,729 held (−0%) $762.57 $42K +5.6%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2551,704 held (−0%) $763.76 $19K +5.4%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 21951,485 held (−0%) $764.40 $167K +5.4%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 27151,214 held (−1%) $765.39 $207K +5.2%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 27950,935 held (−1%) $766.47 $214K +5.1%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 19250,743 held (−0%) $767.39 $147K +4.9%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 10550,638 held (−0%) $768.33 $81K +4.8%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 12750,511 held (−0%) $769.30 $98K +4.7%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1250,499 held (−0%) $770.20 $9K +4.6%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 28350,216 held (−1%) $771.56 $218K +4.4%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 21150,005 held (−0%) $772.56 $163K +4.2%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 22449,781 held (−0%) $773.40 $173K +4.1%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 12149,660 held (−0%) $774.48 $94K +4.0%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 37649,284 held (−1%) $775.46 $292K +3.9%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 6649,218 held (−0%) $776.31 $51K +3.7%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 3849,180 held (−0%) $777.76 $30K +3.5%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 45448,726 held (−1%) $778.64 $354K +3.4%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 38048,346 held (−1%) $779.59 $296K +3.3%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 46347,883 held (−1%) $780.63 $361K +3.2%
Oct 15 NewSEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 5047,833 held (−0%) $781.47 $39K +3.1%
  • Sell

    Co-Chief Scientific Officer Andrew J Murphy sold $5K of REGN at $753.76 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Co-Chief Scientific Officer Andrew J Murphy sold $26K of REGN at $755.91 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Co-Chief Scientific Officer Andrew J Murphy sold $12K of REGN at $757.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Co-Chief Scientific Officer Andrew J Murphy sold $18K of REGN at $758.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Co-Chief Scientific Officer Andrew J Murphy sold $11K of REGN at $759.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Co-Chief Scientific Officer Andrew J Murphy sold $56K of REGN at $760.65 — pre-scheduled 10b5-1 plan sale.